Our sustainable solutions

• Corbion’s biomedical, nutrition, pharma, and food safety solutions positively impact human health (SDG 3).

• Corbion’s biochemicals enable customers to become more circular by switching to biobased alternatives, which helps to reduce the consumption of fossil resources (SDG 12). 

• Corbion's food ingredients solutions extend the shelf life of food products, which can reduce food waste at customers' operations or further downstream (SDG 12).

• Corbion's low-carbon solutions, especially our biobased portfolio, support the transition to a low-carbon economy, contributing to the mitigation of climate change (SDG 13).

• Corbion offers omega-3 derived from algae fermentation as an alternative to traditional fish oil, a nature-based solution that reduces negative impacts on marine biodiversity (SDG 14).

These sustainable solutions can all be linked to specific downstream opportunities and positive impacts related to Climate change, Biodiversity, Circular economy, and Consumer health. Since we use a similar entity-specific metric for each of these topics, they are disclosed in this separate chapter which is focused on our positive impact and the related business opportunities.

How we manage our impact: strategy and governance

Impacts, risks, and opportunities

Our sustainable solutions are based on the following opportunities and positive impacts identified in the DMA.

Policies

Our Climate Policy includes a commitment related to the positive impacts of our low-carbon solutions. Corbion is also highly committed to contributing to climate-change mitigation through our low carbon solutions. We are dedicated to expanding the use of biobased products, therefore enabling the phasing out of fossil feedstocks for our customers. We do not address our positive impacts on Biodiversity, Circular economy, and Consumer health in policies.

Actions and progress

To capture the opportunities available, we focus our investments on several key areas to drive future growth and innovation. One major area of investment is in algae ingredients, particularly omega-3 oils. This investment aims to enhance our capabilities in producing sustainable and high-quality omega-3 products for use in aquaculture, pet food, and human nutrition. Additionally, Corbion is investing in biomedical polymers. This investment supports the development of advanced materials for medical applications, reinforcing our commitment to innovation in the biomedical field. 

We assess new product development projects on their potential contribution to the United Nations Sustainable Development Goals (SDGs 2, 3, 12, 13, 14) to ensure that our innovation efforts are focused on increasing our positive impact on Climate change, Biodiversity, Circular economy, and Consumer health. The assessment is integrated into our innovation stage-gate process and guides the product developers on sustainability-related matters. This warrants that sustainability is an integrated part of the product design.

To ensure reliable information about the benefits of our solutions, we use Life Cycle Assessments (LCA) to understand the environmental impacts of our products. An LCA can be used as a scientific basis to identify improvement opportunities, compare different products, and support decision making in new product and process development. We provide this information to customers, to help them understand our products' carbon footprint and substantiate their sustainability claims. All Corbion LCAs are peer reviewed according to ISO 14040/44 and ISO 14067 standards. 

To monitor our impact, we track the overall contribution to the SDGs as a percentage of Corbion’s total revenues. In 2024, 74% of our revenues contributed to the SDGs. We aim to increase this percentage by increased investments in key growth areas such as natural food preservation, algae-based ingredients, lactic acid derivatives, and natural polymers. This includes investments in innovation, where all innovation projects are expected to contribute to the SDGs. These investments allow Corbion to take advantage of opportunities related to Climate change, Biodiversity, Circular economy, and Consumer health.

Metrics